The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer

The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer

Targeted therapies have allowed for an individualized treatment approach in non-small-cell lung cancer (NSCLC). The initial therapeutic decisions and success of targeted therapy depend on genetic identification of personal tumor profiles. Tissue biopsy is the gold standard for molecular analysis, bu...

Full description

Bibliographic Details
Main Authors: Jatta Saarenheimo, Natalja Eigeliene, Heidi Andersen, Marja Tiirola, Antti Jekunen
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Oncology
Subjects:
ctDNA
NSCLC
EGFR
personalized therapy
cancer
precision medicine
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00129/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00129/full

Similar Items